» Articles » PMID: 11581314

Deficiency of Small GTPase Rac2 Affects T Cell Activation

Overview
Journal J Exp Med
Date 2001 Oct 3
PMID 11581314
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Rac2 is a hematopoietic-specific GTPase acting as a molecular switch to mediate both transcriptional activation and cell morphological changes. We have examined the effect of Rac2 deficiency during T cell activation. In Rac2(-/-) T cells, proliferation was reduced upon stimulation with either plate-bound anti-CD3 or T cell receptor-specific antigen. This defect is accompanied with decreased activation of mitogen activated protein kinase extracellular signal-regulated kinase (ERK)1/2 and p38, and reduced Ca(2)+ mobilization. TCR stimulation-induced actin polymerization is also reduced. In addition, anti-CD3 cross-linking-induced T cell capping is reduced compared with wild-type T cells. These results indicate that Rac2 is important in mediating both transcriptional and cytoskeletal changes during T cell activation. The phenotypic similarity of Rac2(-/-) to Vav(-/-) cells implicates Rac2 as a downstream mediator of Vav signaling.

Citing Articles

RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation.

Doye A, Chaintreuil P, Lagresle-Peyrou C, Batistic L, Marion V, Munro P J Exp Med. 2024; 221(10).

PMID: 39212656 PMC: 11363864. DOI: 10.1084/jem.20231562.


Hyperactive Rac stimulates cannibalism of living target cells and enhances CAR-M-mediated cancer cell killing.

Mishra A, Rodriguez M, Torres A, Smith M, Rodriguez A, Bond A Proc Natl Acad Sci U S A. 2023; 120(52):e2310221120.

PMID: 38109551 PMC: 10756302. DOI: 10.1073/pnas.2310221120.


A systems and computational biology perspective on advancing CAR therapy.

Tserunyan V, Finley S Semin Cancer Biol. 2023; 94:34-49.

PMID: 37263529 PMC: 10529846. DOI: 10.1016/j.semcancer.2023.05.009.


Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell.

Liu R, Li T, Zhang G, Jia Y, Liu J, Pan L Stem Cells Int. 2023; 2023:8485726.

PMID: 37214785 PMC: 10198763. DOI: 10.1155/2023/8485726.


Rho GTPases as Key Molecular Players within Intestinal Mucosa and GI Diseases.

Pradhan R, Ngo P, Martinez-Sanchez L, Neurath M, Lopez-Posadas R Cells. 2021; 10(1).

PMID: 33406731 PMC: 7823293. DOI: 10.3390/cells10010066.


References
1.
Diekmann D, Abo A, Johnston C, Segal A, Hall A . Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science. 1994; 265(5171):531-3. DOI: 10.1126/science.8036496. View

2.
Khosravi-Far R, Solski P, Clark G, Kinch M, Der C . Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol. 1995; 15(11):6443-53. PMC: 230895. DOI: 10.1128/MCB.15.11.6443. View

3.
Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D . A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994; 78(6):1027-37. DOI: 10.1016/0092-8674(94)90277-1. View

4.
Chong L, Bokoch G, Schwartz M . The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell. 1994; 79(3):507-13. DOI: 10.1016/0092-8674(94)90259-3. View

5.
Valitutti S, Dessing M, Aktories K, Gallati H, Lanzavecchia A . Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J Exp Med. 1995; 181(2):577-84. PMC: 2191861. DOI: 10.1084/jem.181.2.577. View